loadpatents
Patent applications and USPTO patent grants for Malavaud; Bernard.The latest application filed is for "inhibition of chemokine ccl7 or receptor ccr3 of same for the treatment and diagnosis of prostate cancer".
Patent | Date |
---|---|
Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer App 20200081009 - Muller; Catherine ;   et al. | 2020-03-12 |
Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer Grant 10,401,365 - Muller , et al. Sep | 2019-09-03 |
Microdevice for the In Vivo Capture of Circulating Cellular Biomarkers App 20180049726 - Cerf; Aline ;   et al. | 2018-02-22 |
Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer App 20170131282 - Muller; Catherine ;   et al. | 2017-05-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.